97 related articles for article (PubMed ID: 15791565)
1. beta-catenin and its regulatory network.
Klymkowsky MW
Hum Pathol; 2005 Mar; 36(3):225-7. PubMed ID: 15791565
[No Abstract] [Full Text] [Related]
2. [Wnt signaling abnormalities in human lung cancer].
Sunaga N; Kohno T; Yokota J
Nihon Rinsho; 2002 May; 60 Suppl 5():733-6. PubMed ID: 12101774
[No Abstract] [Full Text] [Related]
3. Development. Missized mutants help identify organ tailors.
Vogel G
Science; 2002 Jul; 297(5580):328. PubMed ID: 12130764
[No Abstract] [Full Text] [Related]
4. Decisions, decisions: beta-catenin chooses between adhesion and transcription.
Harris TJ; Peifer M
Trends Cell Biol; 2005 May; 15(5):234-7. PubMed ID: 15866026
[TBL] [Abstract][Full Text] [Related]
5. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
Hill TP; Später D; Taketo MM; Birchmeier W; Hartmann C
Dev Cell; 2005 May; 8(5):727-38. PubMed ID: 15866163
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
7. Wnt/beta-catenin--a canonical tale of cell-fate choice in the vertebrate skeleton.
Kolpakova E; Olsen BR
Dev Cell; 2005 May; 8(5):626-7. PubMed ID: 15866155
[TBL] [Abstract][Full Text] [Related]
8. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
9. [Record no. 22: Beta-catenin].
Soussi T
Bull Cancer; 1999 Mar; 86(3):244. PubMed ID: 10847717
[No Abstract] [Full Text] [Related]
10. Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamine-induced hepatocellular carcinomas in rats.
Hara A; Sakata K; Yamada Y; Kuno T; Kitaori N; Oyama T; Hirose Y; Murakami A; Tanaka T; Mori H
Oncol Rep; 2005 Aug; 14(2):345-51. PubMed ID: 16012713
[TBL] [Abstract][Full Text] [Related]
11. Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis.
Day TF; Guo X; Garrett-Beal L; Yang Y
Dev Cell; 2005 May; 8(5):739-50. PubMed ID: 15866164
[TBL] [Abstract][Full Text] [Related]
12. Increased seizure susceptibility and cortical malformation in beta-catenin mutant mice.
Campos VE; Du M; Li Y
Biochem Biophys Res Commun; 2004 Jul; 320(2):606-14. PubMed ID: 15219872
[TBL] [Abstract][Full Text] [Related]
13. Expression of beta-catenin, E-cadherin and cyclin D1 in adenoid cystic carcinoma of the salivary gland.
Daa T; Kaku N; Kashima K; Nakayama I; Yokoyama S
J Exp Clin Cancer Res; 2005 Mar; 24(1):83-7. PubMed ID: 15943036
[TBL] [Abstract][Full Text] [Related]
14. BMP-2-modulated chondrogenic differentiation in vitro involves down-regulation of membrane-bound beta-catenin.
Zhang WV; Stott NS
Cell Commun Adhes; 2004; 11(2-4):89-102. PubMed ID: 16194878
[TBL] [Abstract][Full Text] [Related]
15. Expression of beta-catenin in human testes with spermatogenic defects.
Lee JH; Choi KW; Lee SJ; Gye MC
Arch Androl; 2005; 51(4):271-6. PubMed ID: 16036634
[TBL] [Abstract][Full Text] [Related]
16. Wnt/beta-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-distal patterning in the lung.
Shu W; Guttentag S; Wang Z; Andl T; Ballard P; Lu MM; Piccolo S; Birchmeier W; Whitsett JA; Millar SE; Morrisey EE
Dev Biol; 2005 Jul; 283(1):226-39. PubMed ID: 15907834
[TBL] [Abstract][Full Text] [Related]
17. [Beta-catenin and cell proliferation in normal and transformed intestinal cells].
Hamelin R; Duval A
Med Sci (Paris); 2003; 19(8-9):788-90. PubMed ID: 14593607
[No Abstract] [Full Text] [Related]
18. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
[TBL] [Abstract][Full Text] [Related]
19. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
Hauben EI; Jundt G; Cleton-Jansen AM; Yavas A; Kroon HM; Van Marck E; Hogendoorn PC
Hum Pathol; 2005 Sep; 36(9):1025-30. PubMed ID: 16153468
[TBL] [Abstract][Full Text] [Related]
20. Functional correlates of mutation of the Asp32 and Gly34 residues of beta-catenin.
Provost E; McCabe A; Stern J; Lizardi I; D'Aquila TG; Rimm DL
Oncogene; 2005 Apr; 24(16):2667-76. PubMed ID: 15829978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
